LoginRegister

    Abbott India Q2 profit rises 83 percent to Rs 137.52 crore

    Written by Ruby Khatun Khatun   |  

    New Delhi: Drug firm Abbott India reported 83.31% jump in net profit to Rs137.52 crore for the September quarter on account of robust sales.


    It had posted a net profit of Rs75.02 crore for the corresponding period of last fiscal, Abbott India said in a filing to BSE.


    The total income of the company also rose to Rs946.04 crore for the July-September quarter of 2017-18 as against Rs743.78 crore in the same quarter of 2016-17.

    AbbottAbbott IndiaFinancial resultsnet profitpharma newsprofitQ2 resultssecond quarterSeptember quarter
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X